2023
The Current State of Liver Transplantation for Colorectal Liver Metastases in the United States: A Call for Standardized Reporting
Sasaki K, Ruffolo L, Kim M, Fujiki M, Hashimoto K, Imaoka Y, Melcher M, Aucejo F, Tomiyama K, Hernandez-Alejandro R. The Current State of Liver Transplantation for Colorectal Liver Metastases in the United States: A Call for Standardized Reporting. Annals Of Surgical Oncology 2023, 30: 2769-2777. PMID: 36719568, PMCID: PMC9888331, DOI: 10.1245/s10434-023-13147-6.Peer-Reviewed Original ResearchConceptsColorectal liver metastasesLiving donor LTLiver transplantationLiver metastasesNonresectable colorectal liver metastasesSurvival rateTime of LTOverall survival rateMELD-Na scoreDDLT groupLT patientsTransplant center characteristicsOncological historyDisease-freeTherapeutic optionsPatient selectionLiver tumorsHepatocellular carcinomaTransplant oncologyU.S. transplant centersPosttransplant outcomesSharing databaseTransplant centersUNOS dataPatients
2020
Big Data in Transplantation Practice-the Devil Is in the Detail-Fontan-associated Liver Disease.
Kim M, Nguyen A, Lo M, Kumar S, Bucuvalas J, Glynn E, Hoffman M, Fischer R, Emamaullee J. Big Data in Transplantation Practice-the Devil Is in the Detail-Fontan-associated Liver Disease. Transplantation 2020, 105: 18-22. PMID: 32639398, DOI: 10.1097/tp.0000000000003308.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAge FactorsAgedAged, 80 and overBig DataChildChild, PreschoolData CollectionData MiningDatabases, FactualFemaleFontan ProcedureHeart Defects, CongenitalHumansInfantInfant, NewbornLiver DiseasesLiver TransplantationMaleMiddle AgedRisk AssessmentRisk FactorsTreatment OutcomeYoung AdultConceptsFontan-associated liver diseasePatients post-FontanPost-FontanLiver diseaseSingle-ventricle heart diseaseHeart-liver transplantationProgressive hepatic fibrosisMultiple health systemsConsequences of chronic exposureFontan procedureFontan RegistryNoncardiac complicationsHeart-liverTime of heartFontan hemodynamicsLiver transplantationHepatocellular carcinomaFontanHepatic fibrosisIndividual patientsHeart diseasePatientsHealth systemAffected childrenTransplantation
2019
Immunologic benefit of maternal donors in pediatric living donor liver transplantation
Kim M, Akbari O, Genyk Y, Kohli R, Emamaullee J. Immunologic benefit of maternal donors in pediatric living donor liver transplantation. Pediatric Transplantation 2019, 23: e13560. PMID: 31402535, DOI: 10.1111/petr.13560.Peer-Reviewed Original ResearchMeSH KeywordsChildGraft RejectionGraft SurvivalHumansLiver TransplantationLiving DonorsMothersTransplantation, HomologousTreatment OutcomeConceptsLDLT recipientsPediatric LDLT recipientsPediatric LDLTImmune tolerancePost-transplantPrimary diagnosis of biliary atresiaImpact of graft typeMechanisms of immune toleranceDiagnosis of biliary atresiaOperational toleranceImprove outcomesLong-term follow-upPediatric LDLT patientsWithdrawal of immunosuppressionRegulatory T cellsImproving allograft survivalTime post-transplantDonor liver transplantationDeceased donor recipientsMaternal-fetal microchimerismRate of rejectionLDLT patientsAllograft survivalBiliary atresiaPatient survival